TAZORAC

Almirall, LLC🇺🇸 United States

FDA Page

Effective Date: Dec 15, 2022
Approval ID: 021744d1-a6d7-4ad6-99c2-7187c24e64c6
Products: 2 registered
Version: 3

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use TAZORAC Cream safely and effectively. See full prescribing information for TAZORAC Cream. TAZORAC (tazarotene) cream, 0.05% and 0.1%, for topical use Initial U.S. Approval: 1997

Quick Stats

Total Products2

Labelers2

Label Sections24

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.